. . . . . . . . . "incruse ellipta is indicated for the long term once daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease copd including chronic bronchitis and or emphysema incruse ellipta is an anticholinergic indicated for the long term once daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease copd 1" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "RsoCSjXH1/kY/AIHXPbzRdBvPwYQB+jNv1SRz+E2B2EYPuC14xPVKkne7lV3u6ZwTBHFzq/5HuE2A36KwlbkTi7FyyTaVbilyu2QJiT4yfg52EYy/YnSsDQ2Na4HroGIviVRBmu6ryezuExzxoJD+Lw8ZRAjEZmBOI/oO9JW8XI=" . . "2021-07-03T14:41:07.966+02:00"^^ . . . . .